| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |